118 related articles for article (PubMed ID: 24750260)
1. Growing teratoma syndrome: clinical and radiographic characteristics.
Lee DJ; Djaladat H; Tadros NN; Movassaghi M; Tejura T; Duddalwar V; Daneshmand S
Int J Urol; 2014 Sep; 21(9):905-8. PubMed ID: 24750260
[TBL] [Abstract][Full Text] [Related]
2. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience.
Spiess PE; Kassouf W; Brown GA; Kamat AM; Liu P; Gomez JA; Tu SM; Tannir NM; Pisters LL
J Urol; 2007 Apr; 177(4):1330-4; discussion 1334. PubMed ID: 17382725
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and management of the growing teratoma syndrome: A single-center experience and review of the literature.
Paffenholz P; Pfister D; Matveev V; Heidenreich A
Urol Oncol; 2018 Dec; 36(12):529.e23-529.e30. PubMed ID: 30446456
[TBL] [Abstract][Full Text] [Related]
4. What is the role of enlarged lymph node resection alone in patients with nonseminomatous germ cell tumor who had stage II or III disease?
Ekenel M; Keskin S; Sanli Ö; Bavbek S; Tunç M; Ander H; Ozcan F; Kiliçaslan I; Başaran M
Clin Genitourin Cancer; 2012 Sep; 10(3):185-9. PubMed ID: 22682983
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pathological features predictive of nephrectomy at post-chemotherapy retroperitoneal lymph node dissection.
Cary KC; Beck SD; Bihrle R; Foster RS
J Urol; 2013 Mar; 189(3):812-7. PubMed ID: 23017517
[TBL] [Abstract][Full Text] [Related]
6. The role of retroperitoneal lymphadenectomy in mature teratoma of the testis.
Heidenreich A; Moul JW; McLeod DG; Mostofi FK; Engelmann UH
J Urol; 1997 Jan; 157(1):160-3. PubMed ID: 8976241
[TBL] [Abstract][Full Text] [Related]
7. Post-chemotherapy nerve-sparing laparoscopic retroperitoneal lymph node dissection in stage IIB testicular cancer.
Kimura Y; Nakamura T; Kawauchi A; Kawabata G; Hongo F; Miki T
Int J Urol; 2013 Aug; 20(8):837-41. PubMed ID: 23305547
[TBL] [Abstract][Full Text] [Related]
8. Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection.
Johnston P; Beck SD; Cheng L; Masterson TA; Bihrle R; Kesler K; Foster RS
J Urol; 2013 Sep; 190(3):874-7. PubMed ID: 23517745
[TBL] [Abstract][Full Text] [Related]
9. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
10. ["Growing teratoma syndrome": an unrecognized complication of treated germ cell tumors of the testis].
Ghaouti M; Roquet L; Fazzalari L; Sibert L; Sabourin JC
Ann Pathol; 2013 Dec; 33(6):402-5. PubMed ID: 24331722
[TBL] [Abstract][Full Text] [Related]
11. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
12. [Growing teratoma syndrome].
Ponce de León Roca J; Villavicencio Mavrich H
Arch Esp Urol; 2000; 53(6):547-52. PubMed ID: 11002523
[TBL] [Abstract][Full Text] [Related]
13. Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection.
Carver BS; Bianco FJ; Shayegan B; Vickers A; Motzer RJ; Bosl GJ; Sheinfeld J
J Urol; 2006 Jul; 176(1):100-3; discussion 103-4. PubMed ID: 16753380
[TBL] [Abstract][Full Text] [Related]
14. Presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLND.
Inci K; Dogan HS; Akdogan B; Baydar DE; Ergen A; Ozen H
Urol Oncol; 2011; 29(1):38-42. PubMed ID: 19269199
[TBL] [Abstract][Full Text] [Related]
15. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
[TBL] [Abstract][Full Text] [Related]
16. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
Williams SB; Steele GS; Richie JP
J Urol; 2009 Dec; 182(6):2716-20. PubMed ID: 19836777
[TBL] [Abstract][Full Text] [Related]
17. Retroperitoneal vascular surgery for the treatment of giant growing teratoma syndrome.
Stella M; Gandini A; Meeus P; Aleksic I; Flechon A; Cropet C; Droz JP; Rivoire M
Urology; 2012 Feb; 79(2):365-70. PubMed ID: 22173179
[TBL] [Abstract][Full Text] [Related]
18. The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis.
Lorigan JG; Eftekhari F; David CL; Shirkhoda A
AJR Am J Roentgenol; 1988 Aug; 151(2):325-9. PubMed ID: 2839969
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant surgery in testicular cancer patients undergoing postchemotherapy retroperitoneal lymph node dissection.
Djaladat H; Nichols C; Daneshmand S
Ann Surg Oncol; 2012 Jul; 19(7):2388-93. PubMed ID: 22395993
[TBL] [Abstract][Full Text] [Related]
20. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
Heidenreich A; Albers P; Hartmann M; Kliesch S; Kohrmann KU; Krege S; Lossin P; Weissbach L;
J Urol; 2003 May; 169(5):1710-4. PubMed ID: 12686815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
